Listar por autor "PEDRO PABLO MARTINEZ VEGA"

A canine model of experimental infection with Leishmania (L.) mexicana

JULIO VLADIMIR CRUZ CHAN; LILIANA ESTEFANIA VILLANUEVA LIZAMA; PEDRO PABLO MARTINEZ VEGA; MARIA JESUS RAMIREZ SIERRA; MIGUEL ENRIQUE ROSADO VALLADO; JOSE LEONARDO GUILLERMO CORDERO; ERIC OLIVIER DUMONTEIL

Cutaneous leishmaniasis is a tropical disease affecting over one million patients annually and Leishmania (L.) mexicana is one of the major etiological agents in the Americas. Here we established the first experimental ...

A canine model of experimental infection with Leishmania (L.) mexicana

PEDRO PABLO MARTINEZ VEGA

Associated Factors to Seroprevalence of Ehrlichia spp. in Dogs of Quintana Roo, Mexico

PEDRO PABLO MARTINEZ VEGA; MANUEL EMILIO BOLIO GONZALEZ; ROGER IVAN RODRIGUEZ VIVAS; EDUARDO GUTIERREZ BLANCO; CARLOS ENRIQUE PEREZ OSORIO; CARLOS HUMBERTO SAURI ARCEO

Associated factors to seroprevalence of Ehrlichia spp. in dogs of Quintana Roo, Mexico

CARLOS ENRIQUE PEREZ OSORIO; PEDRO PABLO MARTINEZ VEGA; MANUEL EMILIO BOLIO GONZALEZ; ROGER IVAN RODRIGUEZ VIVAS; EDUARDO GUTIERREZ BLANCO; SANDRA LUZ DE LOURDES VILLEGAS PEREZ; CARLOS HUMBERTO SAURI ARCEO

The objective of this study was to determine the seroprevalence to Ehrlichia spp. in dogs from Xcalak, Quintana Roo, Mexico, and the associated factors. Serum samples were obtained from 118 dogs and used in an indirect ...

Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice

PEDRO PABLO MARTINEZ VEGA

From Genome Screening to Creation of Vaccine Against Trypanosoma cruzi by Use of Immunoinformatics

PEDRO PABLO MARTINEZ VEGA

Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice

PEDRO PABLO MARTINEZ VEGA

Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors

PEDRO PABLO MARTINEZ VEGA